Transformative Advances in Cancer Immunotherapy: Progress and Promise
Transformative Advances in Cancer Immunotherapy: Progress and Promise
19 PagesThis white paper explores the revolutionary progress in cancer immunotherapy, which utilizes the body’s immune system to combat cancer. Key approaches include immune checkpoint inhibitors (ICIs), CAR T-cell therapy, tumor-infiltrating lymphocytes (TILs), cancer vaccines, oncolytic viruses, and bispecific and trispecific antibodies. ICIs, targeting molecules like PD-1, PD-L1, and CTLA-4, have reshaped cancer treatment, though challenges such as variable patient response and immune-related adverse events persist. CAR T-cell therapy has shown promise, particularly in hematological cancers, with ongoing research to enhance its efficacy in solid tumors.
